The Supreme Court upheld access to the commonly used medication abortion drug mifepristone in a unanimous decision Thursday, wiping out a lower-court opinion that would have restricted access.
The justices ruled that an association of doctors who object to abortion could not meet the legal standard for bringing a challenge to Food and Drug Administration rules that made mifepristone easier for doctors to prescribe and for pregnant women to obtain.
Justice Brett M. Kavanaugh wrote the opinion for the court, which said the doctors could not prove they were harmed by the FDA’s decisions to expand access to the drug nationwide in 2016, 2021 and 2023.
